01. Doctor Overview

Doctor Overview

Dr. Vincent Mase is a board-certified thoracic surgeon in the Yale Thoracic Surgery department and is privileged at the following locations:

  • Chief of Thoracic Surgery at Bridgeport Hospital
  • Park Avenue Medical Center, Trumbull, CT
  • Smilow Cancer Hospital, New Haven, CT
  • Greenwich Hospital
  • Saint Raphael’s Hospital, New Haven, CT
  • West Haven Veteran Affairs Center

He is an assistant professor of surgery at Yale School of Medicine. Dr. Mase currently serves as Colonel in the U.S. Army Reserves. He has served for almost 25 years, including active duty and reserves with a one-year combat deployment to Tikrit, Iraq and overseas tours including Schweinfurt, Germany and Seoul, South Korea. His military awards include Bronze Star Medal, Meritorious Service Medal, Combat Medical Badge, Korean Defense Service Medal, Army Commendation Medal, Army Achievement Medal (2nd Award), Meritorious Unit Commendation, Valorous Unit Award, National Defense Service Medal, Global War on Terrorism Expeditionary Medal, Global War on Terrorism Service Medal, Army Service Ribbon, Overseas Service Ribbon (3rd Award) and Armed Forces Reserve Medal with M Device.

Dr. Mase did his thoracic fellowship at the Brigham and Women’s Hospital and had extensive mesothelioma surgical training under the direction of Dr. Raphael Bueno. Dr. Mase specializes in surgical treatment of lung cancer, chest wall deformities and other conditions that affect the chest. He is board certified in both general surgery and thoracic surgery. He also has experience performing minimally invasive surgery.

Dr. Mase is involved in clinical research for lung cancer. He has collaborated with other specialists on numerous published articles and studies.

When working with patients, particularly those diagnosed with mesothelioma, Dr. Mase realized for many this is the patient’s first experience with a cancer diagnosis. And for many, the first time needing a medical procedure or being in the hospital. Dr. Mase works to make sure patients and their families understand the disease process and all treatment options. In addition, Dr. Mase is passionate about ensuring all veterans understand what benefits they may have through the VA.

02. Fast Facts

Doctor Fast Facts

Main Specialty: Thoracic Surgery

Other Interests & Specialties: General surgery, cardiovascular surgery, lung cancer, chest wall deformities and other conditions affecting the chest.

Certifications, Awards & Accolades: American Board of Thoracic Surgery Certification in Thoracic Surgery, American Board of Surgery Certification in General Surgery

Education & Experience:

  • Medical Degree from University of Vermont College of Medicine
  • Internship in General Surgery at Walter Reed Army Medical Center
  • Residency and Internship in General Surgery at Fletcher Allen Healthcare
  • Fellowship at Brigham and Women’s Hospital
  • Currently enrolled in the Executive MBA program at the University of Connecticut (UCONN) School of Business
03. Publications


Brief report: increasing prevalence of ground-glass nodules and semisolid lung lesions on outpatient chest computed tomography scans. JTO Clin Res Rep. 2023;4(12):100583.

Impact of the covid-19 pandemic on lung cancer screening processes in a northeast tertiary health care network. J Comput Assist Tomogr. 2023 Oct 12.

Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. J Thorac Cardiovasc Surg. 2023 Jul 25;S0022-5223(23)00625-6.

The evidence behind lung cancer screening: a narrative review of randomized clinical trials. Curr Chall Thorac Surg. 2023;5.

Comparing a novel hand-held device for chest tube insertion to the traditional open tube thoracostomy for simple pneumothorax in a porcine model. J Spec Oper Med. 2022 Dec 16;22(4):41–5.

Formal military civilian affiliations are a template for low military cardiothoracic surgery volume. Ann Thorac Surg. 2022 Sep;114(3):621–4.

Surgical management of pneumothorax and pleural space disease. Surg Clin North Am. 2022 Jun;102(3):413–27.

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation. J Thorac Dis. 2022 Jun;14(6):2412–36.

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. J Thorac Dis. 2022 Jun;14(6):2387–411.

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients. J Thorac Dis. 2022 Jun;14(6):2357–86.

A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-making. J Thorac Dis. 2022 Jun;14(6):2340–56.

Association between food and drug administration approval and disparities in immunotherapy use among patients with cancer in the us. JAMA Netw Open. 2022 Jun 1;5(6):e2219535.

Revisiting indications for brain imaging during the clinical staging evaluation of lung cancer. JTO Clin Res Rep. 2022 May;3(5):100318.

A national study of surgically managed atypical pulmonary carcinoid tumors. Ann Thorac Surg. 2021 Sep;112(3):921–7.

Navigating by stars: using cms star ratings to choose hospitals for complex cancer surgery. JNCI Cancer Spectr. 2020 Oct;4(5):pkaa059.

Invasive staging procedures do not prevent nodal metastases from being missed in stage i lung cancer. Ann Thorac Surg. 2020 Aug;110(2):390–7.

Surgically managed signet ring cell esophageal carcinomas in the national cancer database. Ann Thorac Surg. 2020 Jun;109(6):1656–62.

Approach to the subsolid nodule. Clin Chest Med. 2020 Mar;41(1):99–113.

Transfusion for shock in US military war casualties with and without tourniquet use. Ann Emerg Med. 2015 Mar;65(3):290–6.

Poloxamer-188 reduces muscular edema after tourniquet-induced ischemia-reperfusion injury in rats. J Trauma. 2011 May;70(5):1192–7.

Admission physiology criteria upon presentation to combat support hospitals; are current critical vital signs effective? Journal of the American College of Surgeons. 2010 Sep;211(3):S106.

Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics. 2010 Jul 13;33(7):511.

Effect of skeletal muscle ischemia‐reperfusion (I/r) postconditioning (Post c) on antioxidant status in rats. The FASEB Journal. 2010 Apr;24(S1).